The network as the target

The conventional target centric model of drug discovery is pinned under the weight of prior success and the traditional problems of safety and efficacy for new molecules. An alternative to target centric drug development is to shift focus to the pathways that mediate both biology and pathophysiology. This method has the advantage of not requiring a priori knowledge of the small molecule target, but also comes with it several challenges including target determination. We suggest extending this notion more broadly across the drug discovery process using quantitative network structure‐activity relationships (QNSAR), and discuss the steps necessary to test the hypothesis that systems biology approaches can be used to improve the drug discovery process. Copyright © 2009 John Wiley & Sons, Inc.

[1]  J J Baldwin,et al.  Application of the three-dimensional structures of protein target molecules in structure-based drug design. , 1994, Journal of medicinal chemistry.

[2]  Ronald W. Davis,et al.  Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar–coding strategy , 1996, Nature Genetics.

[3]  Ronald W. Davis,et al.  Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. , 1999, Science.

[4]  James R. Knight,et al.  A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.

[5]  P. Zipperlen,et al.  Functional genomic analysis of C. elegans chromosome I by systematic RNA interference , 2000, Nature.

[6]  B. Schwikowski,et al.  A network of protein–protein interactions in yeast , 2000, Nature Biotechnology.

[7]  Loren Miraglia,et al.  TORCs: transducers of regulated CREB activity. , 2003, Molecular cell.

[8]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.

[9]  Frederick J. King,et al.  Genome-scale functional profiling of the mammalian AP-1 signaling pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Serge Batalov,et al.  Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. , 2003, Molecular cell.

[11]  Robert W. Williams,et al.  WebQTL - Web-based complex trait analysis , 2003, Neuroinformatics.

[12]  J. C. Hinshaw,et al.  Discovering Modes of Action for Therapeutic Compounds Using a Genome-Wide Screen of Yeast Heterozygotes , 2004, Cell.

[13]  Serge Batalov,et al.  Use of a Dense Single Nucleotide Polymorphism Map for In Silico Mapping in the Mouse , 2004, PLoS biology.

[14]  S. L. Wong,et al.  A Map of the Interactome Network of the Metazoan C. elegans , 2004, Science.

[15]  N. Perrimon,et al.  Genome-Wide RNAi Analysis of Growth and Viability in Drosophila Cells , 2004, Science.

[16]  Bernardo A Mangiola,et al.  A Drosophila protein-interaction map centered on cell-cycle regulators , 2004, Genome Biology.

[17]  Mark C. Fishman,et al.  Pharmaceuticals: A new grammar for drug discovery , 2005, Nature.

[18]  A. Coulson,et al.  Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans , 2005, Nature.

[19]  Mark Craven,et al.  EDGE: A Centralized Resource for the Comparison, Analysis, and Distribution of Toxicogenomic Information , 2005, Molecular Pharmacology.

[20]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[21]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[22]  P. Imming,et al.  Drugs, their targets and the nature and number of drug targets , 2006, Nature Reviews Drug Discovery.

[23]  N. Perrimon,et al.  RNA interference screening in Drosophila primary cells for genes involved in muscle assembly and maintenance , 2008, Development.

[24]  Shi-Hua Zhang,et al.  Biomolecular network querying: a promising approach in systems biology , 2008, BMC Systems Biology.

[25]  Roded Sharan,et al.  NetworkBLAST: comparative analysis of protein networks , 2008 .

[26]  Jingyuan Fu,et al.  Genetical Genomics: Spotlight on QTL Hotspots , 2008, PLoS genetics.

[27]  Lilia M. Iakoucheva,et al.  A Protein Domain-Based Interactome Network for C. elegans Early Embryogenesis , 2008, Cell.

[28]  Dave Winkler,et al.  Bayesian Regularization of Neural Networks , 2009, Artificial Neural Networks.

[29]  E. Schadt,et al.  Integrative genomics and drug development. , 2009, Pharmacogenomics.

[30]  Bethan Hughes,et al.  2008 FDA drug approvals , 2009, Nature Reviews Drug Discovery.